Tissue Regeneration Market To Hold A High Potential For Growth By 2027

Press Release

Tissue Regeneration Market Introduction

Tissue regeneration is replacement or repair of tissue which is damaged or diseased by regrowing or replacing it. Congenital diseases, defects, and tissue damage due to diseases drives the need of tissue regeneration. This technique involves tissue engineering process which maintains, restores, and improves damaged tissue function. The tissue regeneration process helps in increasing the life expectancy of patients by replacing the damaged organs, including kidneys. The regenerative medicine offers a potential of resolving shortage of organ donor in present time, For instance tissue reengineered skin is highly useful for skin replacement, burn wounds and ulcers affects leg and foot. In 2013, the number of regeneration procedures performed reached 5.6 million. According to research, 500,000 U.S. citizens benefit from transplants each year

View Report:

Tissue Regeneration Market – Competitive Landscape

Major players operating in the global tissue regeneration market include Isto Biologics, Athersys, Inc., Vericel Corporation, co.don AG, Mesoblast Ltd., Episkin SA, Cook Medical, CryoLife, Inc., Cytori Therapeutics, Inc., Cerapedics, Inc., BioMedical Tissues, Genzyme Corporation, KCI Licensing, Inc., Nuo Therapeutics, Inc., Organogenesis, Inc., Orthopeutics, U.S. Stem Cell, Inc., Wright Medical Group N.V., Biocomposites, BD, Zimmer Biomet, and ACell Inc. Mergers & acquisitions (M&A), partnerships, joint ventures, agreements, and product launches are strategies adopted by the key players to boost growth. Companies are also focused on developing new products and gaining patents for them.

Identify the Key Factors that will drive your Company’s Growth. Request a Brochure of this Report here 

Biomedical Tissues

Biomedical Tissues offers an advance tissue regeneration product which enables the clinical process to be faster and easier with offering comfort and recovery to the patients. Biomedical tissues is a growing pioneer in developing synthetic resorbable membrane and thus offers “Tisseos” product which help regenerating human tissues at faster pace.

CryoLife, Inc.

Inception since 1984, CryoLife Inc., is a pioneer in offering innovative solution for the restoration of patient’s health and improve their quality of life. Company is a renowned leader in offering human tissue used in the cardiac surgeries, vascular surgeries, heart valves replacement, in cardiac lasers for the treatment of refractory angina and others. Since the founding years, the company has successfully implanted its products and tissues in over 1 million patients worldwide. CryoLife, Inc., is a public company with over 700 employees across 11 countries.

Request a Brochure of the Report @

Tissue Regeneration Market Dynamics 

Prevalence of chronic diseases and technological advancements are projected to drive the global tissue regeneration market

Prevalence of chronic diseases, diagnosis of diseases using biomarkers, demand for personalized medicines, and grants & funding by governments across regions are anticipated to boost the growth of the global tissue regeneration market. Increase in applications of 3D printing in tissue regeneration, surge in research & development and innovation in biomaterials, nanotechnology, cell therapies, and drug delivery are likely to augment the global tissue regeneration market. Rise in popularity of the technology owing to efficient products and reduced rejection rates is another factor boosting the awareness, and with each passing year, the regeneration surgeries are also increasing. Application of tissue engineered vascular grafts in cardiovascular disease treatment and surgeries is studied across pre-clinical stage. Advancement in growing tissue engineered bladder outside patient body and its successful transplantation is a rapid development witnessed today.

Stringent regulations projected to hamper the growth of the global tissue regeneration market

Stringent regulations by governments, reimbursement issues especially in the developing countries, and less investments in the underdeveloped regions restrain the global market. Rising cost of organ transplantation and lack of skilled personnel are anticipated to hamper the growth of the global tissue regeneration market. Strict regulatory framework is similar designed across U.S., European Union countries, Japan, and China. For instance in China, the regulatory framework designed for tissue regeneration is not flexible and clear, which is roadblock in companies to understand the scenario in particular country. In most of the major countries, the two tier regulatory framework remains a challenge which is likely to hamper the future of tissue regeneration industry.

Tissue Regeneration Market Segmentation

Based on the technology, the Tissue Regeneration Market is segmented into

  • Cell therapy
  • Stem cell therapy
  • Stem cell sources
  • Tissue vascularization
  • Cell culturing
  • Others

Based on the raw material, the Tissue Regeneration Market is segmented into

  • Synthetic
  • Genetically modified
  • Biological

Request TOC @

Based on the application, the Tissue Regeneration Market is segmented into

  • Cardiovascular
  • Oncology
  • Dermatology
  • Orthopedic
  • Neurology
  • Ophthalmology
  • Others

Based on the end-user, the Tissue Regeneration Market is segmented into

  • Hospital & Diagnostic centers,
  • Pharmaceutical & Biotechnology companies
  • Contract research organizations
  • Others

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]



Related Articles